Zsofia Gal

Ms. Zsofia Gal

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2022 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
ZGZsofia Gal
Zsofia Gal
DTDora Torok
Dora Torok
XGXenia Gonda
Xenia Gonda
NENora Eszlari
Nora Eszlari
IAIan Muir Anderson
Ian Muir Anderson
PPPeter Petschner
Peter Petschner
Evidence from rodents indicated that after recent stress, reduced expression of tight junction protein claudin-5 may weaken the blood-brain barrier and allow interleukin-6 to induce depressive symptoms. Our aims were to prove this pathomechanism in humans. We used a large population genetic database (UK Biobank, n = 277 501) to test whether variation in the CLDN5 gene could modulate effects of the IL6 gene variant in stress-induced depression. Three-way interaction of functional polymorphisms, rs885985 of CLDN5, and rs1800795 of IL6 with recent stressful life events were tested on current depressive symptoms. Analyses were performed in male and female populations as well. The 3-way interaction including recent stress yielded highly significant results on current depressive symptoms in the UK Biobank sample, which was more pronounced in men and could be replicated on trend level in an independent cohort (NewMood, n = 1638). None of any other associations or interactions, including, for example, childhood stressors and lifetime depression as an outcome, yielded significance. These findings provide genetic evidence in humans for the interaction among interleukin-6, claudin-5, and recent stress, suggesting that inflammation is involved in the development of depression and that stress-connected brain entry of inflammatory molecules is a key factor in this pathomechanism. These genetic polymorphisms may help to identify people at higher risk for recent stress-induced depression.

9 April 2019 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
Xenia GondaXenia Gonda
Xenia Gonda
PPPeter Petschner
Peter Petschner
NENora Eszlari
Nora Eszlari
SSSara Sutori
Sara Sutori
ZGZsofia Gal
Zsofia Gal
GBGyorgy Bagdy
Gyorgy Bagdy
Environmental stress and its interaction with genetic variation are key contributors in the development of depression and anxiety, yet there is a failure to identify replicable genetic variants and gene-interaction effects in the background of these psychiatric symptoms. Recently it has been reported that 5-HTTLPR and NOSI interact with financial but not other types of recent stressors in the development of depression. In the present study we investigated the interaction of GABRA6 rs3219151 and CNR1 rs7766029 in interaction with different types of recent life events on the presence of depression and anxiety in a large general population sample. 2191 participants completed the List of Threatening Experiences questionnaire which covers four categories of stressful life events (financial problems, illness/personal problems, intimate relationships, and social network) experienced over the previous year and the Brief Symptom Inventory for depression and anxiety symptoms. Participants were genotyped for rs3219151 and rs7766029. Data were analyzed with linear regression models with age and gender as covariates. Results indicated that CNR1 rs7766029 interacted significantly with financial but not other types of life events both in case of depression and anxiety symptoms. In contrast, GABRA6 rs3219151 showed a significant interaction with social network related life events in case of anxiety and with illness/personal problem-related life events in case of depression. Our results suggest that the psychological impact of different types of recent stress may be differentially modulated by distinct molecular genetic pathways. Furthermore, in case of certain genetic variants, the occurring psychiatric symptom may depend on the type of stress experienced.

25 August 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DBDaniel Baksa
Daniel Baksa
KGKinga Gecse
Kinga Gecse
SKSahel Kumar
Sahel Kumar
ZTZsuzsanna Toth
Zsuzsanna Toth
ZGZsofia Gal
Zsofia Gal
Gabriella JuhaszGabriella Juhasz
Gabriella Juhasz
Several studies suggested that migraine attack onset shows a circadian variation; however, there has not been an overview and synthesis of these findings. A PubMed search with keywords “migraine” AND “circadian” resulted in ten studies directly investigating this topic. Results of these studies mostly show that migraine attacks follow a monophasic 24-hour cyclic pattern with an early morning or late night peak while other studies reported an afternoon peak and also a biphasic 24-hour cycle of attacks. The identified studies showed methodological variation including sample size, inclusion of medication use, comorbidities, and night or shift workers which could have contributed to the contradictory results. Several theories emerged explaining the diurnal distribution of migraine attacks suggesting roles for different phenomena including a morning rise in cortisol levels, a possible hypothalamic dysfunction, a circadian variation of migraine triggers, sleep stages, and a potentially different setting of the circadian pacemaker among migraineurs. At the moment, most studies show an early morning or late night peak of migraine attack onset, but a significant amount of studies reveals contradictory results. Further studies should investigate the arising hypotheses to improve our understanding of the complex mechanism behind the circadian variation of migraine attacks that can shed light on new targets for migraine therapy.

21 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
NGn/a Gézsi
n/a Gézsi
SASandra Van Der Auwera
Sandra Van Der Auwera
HMHannu Mäkinen
Hannu Mäkinen
NENora Eszlari
Nora Eszlari
GHGabor Hullam
Gabor Hullam
Gabriella JuhaszGabriella Juhasz
Gabriella Juhasz
The heterogeneity and complexity of symptom presentation, comorbidities and genetic factors pose challenges to the identification of biological mechanisms underlying complex diseases. Current approaches used to identify biological subtypes of major depressive disorder (MDD) mainly focus on clinical characteristics that cannot be linked to specific biological models. Here, we examined multimorbidities to identify MDD subtypes with distinct genetic and non-genetic factors. We leveraged dynamic Bayesian network approaches to determine a minimal set of multimorbidities relevant to MDD and identified seven clusters of disease-burden trajectories throughout the lifespan among 1.2 million participants from cohorts in the UK, Finland, and Spain. The clusters had clear protective- and risk-factor profiles as well as age-specific clinical courses mainly driven by inflammatory processes, and a comprehensive map of heritability and genetic correlations among these clusters was revealed. Our results can guide the development of personalized treatments for MDD based on the unique genetic, clinical and non-genetic risk-factor profiles of patients.

10 June 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZKZsuliet Kristof
Zsuliet Kristof
NENora Eszlari
Nora Eszlari
SSSara Sutori
Sara Sutori
ZGZsofia Gal
Zsofia Gal
DTDora Torok
Dora Torok
Xenia GondaXenia Gonda
Xenia Gonda
The P2X purinoceptor 7 (P2RX7) mediates inflammatory microglial responses and is implicated in neuroimmune mechanisms of depression and neurodegenerative disorders. A number of studies suggest that psychosocial stress may precipitate depression through immune activation. Genetic association studies of P2RX7 variants with depression have been inconclusive. However, nearly all studies have focused on only one single-nucleotide polymorphism (SNP) and have not considered interaction with psychosocial stress. We investigated the effect of several variations in P2RX7 gene using a clumping method in interaction with early adversities and recent stress on depression severity. 1752 subjects provided information on childhood adversities, recent life events, and current depression severity. Participants were genotyped for 681 SNPs in the P2RX7 gene, 335 of them passed quality control and were entered into linear regression models followed by a clumping procedure for main effect and interactions. No significant main effect was observed. Rs74892325 emerged as a top SNP for interaction with childhood adversities and rs61953400 for interaction with recent life events. Our study is the first to investigate several variants in the P2RX7 gene and in interaction with two types of stress, extending our understanding of neuroinflammation in depression, and supporting that the majority of genes influence depression by enhancing sensitivity to stressors.

25 June 2020 in Frontiers in Psychiatry
Verified
Journal Article
Open access
JBJanos Bokor
Janos Bokor
SKSandor Krause
Sandor Krause
DTDora Torok
Dora Torok
NENora Eszlari
Nora Eszlari
SSSara Sutori
Sara Sutori
Xenia GondaXenia Gonda
Xenia Gonda
Background: Suicide is among the leading causes of death in adolescents and young adults, however, its neurobiological etiology is still not understood. In spite of original reports concerning the involvement of 5-HTTLPR, in interaction with recent stress in the appearance of suicidal ideation and attempts replication attempts have yielded contradictory results. In our study we analysed the association between 5-HTTLPR, lifetime suicide attempts and current suicidal ideation, hopelessness and thoughts of death as main effects and in interaction with childhood adversities, recent stress and different types of recent life events in a general population sample. Methods: 2358 unrelated European volunteers were genotyped for 5-HTTLPR, provided phenotypic data of previous suicide attempts and current suicidal ideation, hopelessness and thoughts about death and information on childhood adversities and recent life events. Logistic and linear regression models were run with age, gender and population as covariates to test for the effect of 5-HTTLPR as a main effect and in interaction with childhood adversities and recent life events on previous suicide attempts and current suicidal ideation. Benjamini-Hochberg FDR Q values were calculated to correct for multiple testing. Results: 5-HTTLPR had no significant effect on lifetime suicide attempts either as a main effect on in interaction with childhood adversities. 5-HTTLPR had a significant main effect on current suicidal ideation in the dominant model (Q=0.0344). 5-HTTLPR did not interact with childhood adversities or total number of recent life events on any phenotypes related to current suicidal risk, however, a significant interaction effect between 5-HTTLPR and current relationship problems emerged in the case of current suicidal ideation in the dominant model (Q=0.0218) and in the case of thoughts about death and dying in the dominant (Q=0.0094) and additive models (Q=0.0281). Conclusion: While 5-HTTLPR did not influence previous suicide attempts or interacted with childhood adversities, it did influence current suicidal ideation with, in addition, an interaction with recent relationship problems supporting the involvement of 5-HTTLPR in suicide. Our findings that 5-HTTLPR impacts only certain types of suicide risk-related behaviours and that it interacts with only distinct types of recent stressors provides a possible explanation for previous conflicting findings.